|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | a phase and pharmacokinetic study o{ the combination of capecitabine and docetaxel in patients with advanced solid tumors 显示文摘 | Pronk L C Vasey P Sparreboom A | 2000 | Br J Cancer2000，83，1： | 1 |
| 2 | Ultrasound-guided continuous oblique subcostal transversus abdominis plane blockade:description of anatomy and clinical technique显示文摘 | Hebbard P D Barrington M J Vasey C | 2010 | Reg Anesth Pain Med2010，35，5： | 1 |
| 3 | Hepatoid ade- nocarcinoma with liver metastasis mimicking hepatocellular carci- noma : an and molecular study of eight cases 显示文摘 | Terracciano L M Glatz K Mhawech P Vasei M | 2003 | Am J Surg Pathol2003，27，10： | 1 |
| 4 | Phase m randomized trial of docetaxel- carboplatin versus paclitaxel -earboplatin as first line chemotherapy for ovarian carcinoma显示文摘 | Vasey P A Jayson G C Gordon A | 2004 | J Natl Cancer Inst2004，96，22： | 1 |
| 5 | The acquisition of hMLH1 methylation in plasma DNA after chemotherapy predicts poor survival for ovarian cancer patients显示文摘 | Gifford G Paul J Vasey P A | 2004 | Clin Cancer Res2004，10，7： | 1 |
| 6 | a phase and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumors 显示文摘 | Vasey P Sparreboom A | 2000 | Br J Cancer2000，83，1： | 1 |
| 7 | A phase Ⅰ and pharmaco kinetic study of the combination of eapecitabine and docetaxel in patients with advanced solid tumors显示文摘 | Pronk LC Vasey P Sparreboom A | 2000 | Br J Canc er2000，83，1： | 1 |
| 8 | a phase and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumors显示文摘 | Vasey P Sparreboom A | 2000 | Br J Cancer2000，83，1： | 1 |
| 9 | Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon,stomach,prostate and lung cancers显示文摘 | Went P Vasei M Bubendorf L | 2006 | Br J Cancer2006，94，1： | 1 |
| 10 | A phase I and Pharma- cokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours显示文摘 | Pronk LC Vasey P Sparreboom A | 2000 | Br J Cancer2000，83，1： | 1 |
| 11 | Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon,stomach,prostate and lung cancers显示文摘 | Went P Vasei M Bubendorf L | 2006 | Br J Canc- er2006，94，1： | 1 |
| 12 | A phase Ⅰ and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours显示文摘 | Pronk LC Vasey P Sparreboom A | 2000 | Br J Cancer2000，83，1： | 1 |
| 13 | A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours显示文摘 | Plonk LC Vasey P Sparreboom A | 2000 | Br J Cancer2000，83，1： | 1 |
| 14 | carboplatin followed by docetaxel or docetaxel-gemcitabine as first-line chemotherapy for ovarian cancer显示文摘 | Vasey P Atkinson R Osborne R | 2006 | Br J Cancer2006，94，1： | 1 |
| 15 | Frequent high-level expression of the immunotherapeufic target Ep-CAM in colon, stomach, prostate and lung cancers显示文摘 | Went P Vasei M Bubendorf L | 2006 | BrJ Cancer2006，94，1： | 1 |
| 16 | A phase and pharma cokinetic study of the combination of capecitabine and docetaxel in patientswith advanced solid tumors 显示文摘 | Pronk LC Vasey P Sparrboom A | 2000 | Br J Cancer2000，83，1： | 1 |
| 17 | Frequent high-level expression of the immunotherapeutic target Ep CAM in colon,stomach,prostate and lung cancers显示文摘 | Went P Vasei M Bubendorf L | 2006 | Br J Cancer2006，94，1： | 1 |
| 18 | Phase Ⅲ randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma 显示文摘 | Vasey P A Jayson G C Gordon A | 2004 | J Natl Cancer Inst2004，96，22： | 1 |
| 19 | Management of renal masses in patients medically unsuitable for nephrectomy- natural history, complications, and outcome显示文摘 | LAMB GW EJ BROMWICH P VASEY | 2004 | Urology2004，64，5： | 1 |
| 20 | Cell cycle arrests and radiosensitivity of human tumor cell lines:dependent on wild-type p53 for radiosensitivity显示文摘 | MoILWRATH A J VASEY P A ROSS G M | 1994 | Cancer Res1994，54，14： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员